| AD | Alzheimer’s disease |
| MetS | Metabolic syndromes |
| DM | Diabetes mellitus |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| 10-HDA | 10-Hydroxy-2-decenoic acid |
| RJ | Royal Jelly |
| ER | Endoplasmic reticulum |
| IR | Insulin resistance |
| MCI | Mild cognitive impairment |
| GLP-1R | Glucagon-like peptide-1 receptor |
| PPARs | Peroxisome proliferator-activated receptors |
| GSK-3 | Glycogen synthase kinase-3 |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| BMI | Body mass index |
| BBB | Blood–brain barrier |
| AGEs | Advanced glycation end products |
| RMSD | Root mean square deviation |